How is Talimogene Laherparepvec Injection dosed?
The dosage of Talimogene Laherparepvec Injection is determined by the patient's specific medical condition and treatment plan. It is given only under the direct supervision of a doctor, injected directly into the tumor(s). The treatment schedule involves receiving the medicine again 3 weeks after the first treatment, followed by injections every 2 weeks for as long as there are remaining tumor(s).
What is the dosage form of Talimogene Laherparepvec Injection?
Talimogene Laherparepvec Injection is available in the form of a suspension.
How is Talimogene Laherparepvec Injection administered?
Talimogene Laherparepvec Injection is administered by a doctor or other trained health professional in a hospital or cancer treatment center. It is injected directly into the tumor(s). The treatment schedule typically involves receiving the medicine again 3 weeks after the first treatment, followed by injections every 2 weeks for as long as there are remaining tumor(s).
What are common precautions when taking Talimogene Laherparepvec Injection?
Common precautions when taking Talimogene Laherparepvec Injection include:
- Allergies: Inform your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines.
- Autoimmune disease, glomerulonephritis, pneumonitis, psoriasis, vasculitis, or vitiligo: Use with caution as these conditions may worsen with Talimogene Laherparepvec Injection.
- Leukemia, lymphoma, or weak immune system: This medicine should not be used in patients with these conditions.
- Multiple myeloma: Talimogene Laherparepvec Injection may increase the risk for more serious side effects in patients with multiple myeloma.
It is essential to follow your doctor's instructions and the Medication Guide carefully. Contact your doctor if you have any questions or concerns regarding the precautions when taking Talimogene Laherparepvec Injection.